Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

Abstract

These data highlight RCC as a ctDNA-low malignancy. The biological reasons for this are yet to be determined. Nonetheless, our findings indicate potential clinical utility in the management of patients with renal tumors, provided improvement in isolation and detection approaches.